Zobrazeno 81 - 90
of 205
pro vyhledávání: '"Edward Kerwin"'
Publikováno v:
Journal of aerosol medicine and pulmonary drug delivery. 32(6)
Background: Asthma is widely treated using inhaled corticosteroid/long-acting beta-agonist combinations, such as fluticasone propionate/salmeterol (FPS) dry powder inhaler. Some regulators...
Autor:
Andrew Fowler, K. Cooper, David I. Bernstein, Steven Pascoe, Zelie Bailes, Edward Kerwin, Robert A. Nathan, Laurie Lee
Publikováno v:
A64. CLINICAL ASTHMA: ASSESSMENT AND TREATMENT.
Autor:
Gary T. Ferguson, Robert Mróz, Diana Jarreta, Rosa Segarra, Esther Garcia Gil, Edward Kerwin, Henrik Watz, Eduard Molins, Sanjay Sethi
Publikováno v:
International Journal of Chronic Obstructive Pulmonary Disease
Sanjay Sethi,1 Edward Kerwin,2 Henrik Watz,3 Gary T Ferguson,4 Robert M Mroz,5,6 Rosa Segarra,7 Eduard Molins,7 Diana Jarreta,7 Esther Garcia Gil7 1Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, SUNY, Buffalo, NY, USA; 2Cli
Autor:
Diana Jarreta, Anna Ribera, Edward Kerwin, Esther Garcia Gil, James F. Donohue, Eduard Molins, Anthony D'Urzo, Ferran Chuecos, Dave Singh
Publikováno v:
International Journal of Chronic Obstructive Pulmonary Disease.
Anthony D D’Urzo,1 Dave Singh,2 James F Donohue,3 Edward M Kerwin,4 Anna Ribera,5 Eduard Molins,5 Ferran Chuecos,5 Diana Jarreta,5 Esther Garcia Gil5 1Department of Family and Community Medicine, Faculty of Medicine, University of Toronto, Toronto,
Autor:
Vaidyanathan Ganapathy, Gary T. Ferguson, Krithika Rajagopalan, Edward Kerwin, Robert Tosiello, James F. Donohue, Vamsi Bollu
Publikováno v:
Chronic obstructive pulmonary diseases (Miami, Fla.). 5(3)
Background: Symptoms of chronic obstructive pulmonary disease (COPD) may diminish patients’ health-related quality of life (HRQoL). We report effects of Longhala™ Magnair™ (glycopyrrolate) Inhalation Solution, a drug/device combination of the l
Autor:
Brett Haumann, Glenn Crater, Sanjay Sethi, Lorna Dean, Srikanth Pendyala, Edmund J. Moran, Edward Kerwin, Chris N. Barnes, James F. Donohue
Publikováno v:
Respiratory Research
Respiratory Research, Vol 20, Iss 1, Pp 1-10 (2019)
Respiratory Research, Vol 20, Iss 1, Pp 1-10 (2019)
Background Revefenacin is a long-acting muscarinic antagonist that was recently approved for the nebulized treatment of chronic obstructive pulmonary disease (COPD). Although shorter duration studies have documented the efficacy of revefenacin in COP
Publikováno v:
Respiratory medicine. 151
Introduction Handheld spirometers for home use by patients allow longitudinal spirometry data to be collected daily and may overcome some of the limitations of in-clinic spirometry (long intervals between measurements, results can be affected by site
Autor:
David A. Lipson, François Maltais, Michael L. Watkins, Paul W. Jones, Ian Naya, Chris Compton, Leif Bjermer, Isabelle Boucot, Lee Tombs, Edward Kerwin
Publikováno v:
COPD: therapeutics and trials.
Introduction Long-acting muscarinic antagonist/long-acting β2-agonist (LAMA/LABA) combination therapy is more effective than monotherapies for improving lung function, breathlessness and health status, in patients with moderate-to-severe COPD (Oba e
Autor:
Jill Walker, Michael L Washburn, Sumita Roy-Ghanta, Phillip J. Yates, Andrew J. Peat, Edward Kerwin, Gary Soucie, G B Roberts, Anuradha Madan, Shuguang Chen
Publikováno v:
Open Forum Infectious Diseases
Background Danirixin (DNX), a selective and reversible CXC chemokine receptor 2 antagonist, inhibits neutrophil transmigration and activation. This study assessed the safety, tolerability, and clinical effect of DNX with and without oseltamivir (OSV)
Autor:
Henrik Watz, Robert Mróz, Gary T. Ferguson, Sanjay Sethi, Diana Jarreta, Edward Kerwin, Eduard Molins, Rosa Segarra, Esther García-Gil
Publikováno v:
Airway pharmacology and treatment.
Background: Aclidinium bromide (AB) and tiotropium (TIO) are long-acting anti-muscarinic COPD maintenance therapies. AB has not been compared with TIO beyond 6 weeks (wks). Aim: To compare efficacy and safety of AB vs TIO at 24 wks in symptomatic pat